IAS 2013: Meta-analysis Finds Early HIV Treatment Reduces Risk of AIDS and Death
- Details
- Category: HIV Treatment
- Published on Wednesday, 24 July 2013 00:00
- Written by Liz Highleyman
A meta-analysis of more than 30 studies found that starting antiretroviral therapy with a CD4 T-cell count above 350 cell/mm3 was associated with a lower risk of progression to AIDS or death, according to a poster presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: HIV/HCV Coinfected Children in Europe Have Poor Hepatitis C Treatment Outcomes
- Details
- Category: HIV/HCV Coinfection
- Published on Wednesday, 24 July 2013 00:00
- Written by Liz Highleyman
HIV/HCV coinfection was uncommon among children and adolescents in a large European cohort, but within this group hepatitis C treatment generally occurred late and rarely led to sustained response, researchers reported at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: HPV Vaccination May Prevent Anal Cancer in Older Gay Men
- Details
- Category: Human Papillomavirus (HPV)
- Published on Wednesday, 24 July 2013 00:00
- Written by Michael Carter
A large number of infections with anal cancer-associated strains of human papillomavirus (HPV) among older gay men could be prevented with the use of HPV vaccines, Australian research reported at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) in Kuala Lumpur. A related analysis showed that high-grade pre-cancerous cell changes were common but often resolved spontaneously.
IAS 2013: Intensive ART During Primary HIV Infection Lowers Viral Reservoir
- Details
- Category: HIV Treatment
- Published on Wednesday, 24 July 2013 00:00
- Written by Liz Highleyman
Starting intensive antiretroviral therapy (ART) with a 5-drug regimen during the earliest stages of HIV infection can result in lower levels of virus in resting T-cell reservoirs, leading to improved immune function and potentially a better chance at a functional cure, according to studies presented at the 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013) this month in Kuala Lumpur.
IAS 2013: Studies Shed More Light on Male Circumcision for HIV Prevention
- Details
- Category: HIV Prevention
- Published on Wednesday, 24 July 2013 00:00
- Written by Gus Cairns
Programs offering voluntary medical male circumcision (VMMC) as part of HIV prevention are now starting to expand in a number countries in sub-Saharan Africa, delegates heard at the recent 7th International AIDS Society Conference on HIV Pathogenesis, Treatment and Prevention (IAS 2013). The conference also heard information about the Shang Ring, one of several new circumcision devices.
Web Design and Development by